Aller au contenu
Checked.be
Rapport d'entreprise complet
Généré 28-06-2026
Actif BE 0540.870.218SA

AQUILON PHARMACEUTICALS

Rue du Bois St-Jean 15/1 ·4102 Seraing, Belgique· 12 ans d'activité
Secteur: NACE 72101 (72101)
Conclusion Checked

La probabilité de faillite calculée de AQUILON PHARMACEUTICALS sur 12 mois est de 0,7% (faible). L'entreprise est active depuis 2013 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.

Sur la base des données du Moniteur belge et de la BCE.
Chiffres clés
Active 12 ans
Sites 4
Publications 13
Probabilité de faillite (12 mois) Modèle Checked v1 · gratuit
0,7% Faible
0%0,5%1,5%4%10%≥25%
Plusieurs unités d'établissement +Secteur à taux de défaillance plus faible −Forme juridique à risque plus faible −

Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?

Évaluation du risque règle-basé
0 / 100
Risque faible
Signaux de confiance 3 signaux
Établie
Constituée en 2013 — 12 ans d'activité.
Aucun incident juridique
Aucune faillite, réorganisation ou administration provisoire au Moniteur belge.
Administrativement en règle
Aucune radiation par le SPF Économie (UBO, comptes, adresse, activité).
Avertissements administratifs 0 événements
Aucun avertissement administratif
Indicateurs financiers10 dépôts BNB
Comptes en cours de traitement
La BNB a 10 dépôt(s) pour cette entreprise — dernier exercice 2024 (volledig). Les comptes annuels sont en cours de traitement.
Dépôts au registre
Exercice Type Dépôt Référence
31-12-2024 volledig 29-07-2025 2025-00322216
31-12-2023 volledig 25-07-2024 2024-00281308
31-12-2022 volledig 10-07-2023 2023-00217875
31-12-2021 volledig 02-08-2022 2022-20260740
31-12-2020 volledig 26-08-2021 2021-54800537
31-12-2019 volledig 16-07-2020 2020-30700174
31-12-2018 volledig 24-06-2019 2019-22500580
31-12-2017 volledig 16-07-2018 2018-33200354
31-12-2016 volledig 12-07-2017 2017-30200388
31-12-2015 volledig 18-07-2016 2016-32800107
Structure juridique
NACE primaire 72101
Forme juridique SA(014)
Date de constitution16-10-2013
StatusActif
Code postal4102
Unités d'établissement 4 sites
AQUILON PHARMACEUTICALS
Rue Porte de Lorette(VIS) 76, 4600 ViséFabrication de produits pharmaceutiques de base
depuis 20132.223.344.621
Aquilon Pharmaceuticals
Quai de la Boverie 59, 4020 LiègeFabrication de produits pharmaceutiques de base
depuis 20192.294.062.371
Aquilon Pharmaceuticals
Rue Auguste Piccard 48, 6041 CharleroiFabrication de produits pharmaceutiques de base
depuis 20192.294.062.470
WSL Labs-aquilon Pharma
Rue du Bois St-Jean 15, 4102 SeraingActivités des laboratoires médicaux
depuis 20212.322.045.782
Sites physiques enregistrés à la Banque-Carrefour des Entreprises (BCE).
Empreinte immobilière Source : BCE × cadastre

Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.

Wallonie 3 (100%)
Parcelle (capakey) Région Superficie Bâtiments Hauteur / ét.
52028B0323/00M003 Wallonie 8 679 m² 1 · 791 m² 18,8 m · 5 ét.
62108C0666/00X000 Wallonie 1 360 m² 1 · 191 m² 8,6 m · 2 ét.
62817C0199/00G002 Wallonie 918 m² 1 · 541 m² —
Méthodologie
via les unités d'établissement : 3
3 des 3 parcelles avec correspondance d'adresse exacte ; les autres sont indicatives.
Liaison sur la base des adresses — ceci ne constitue pas une preuve de propriété.
Mises à jour 23 événements

Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.

2025
16-09-2025
Acte du Moniteur Changement d'administrateurs
29-07-2025
Dépôt BNB Comptes annuels déposés
exercice 2024 · volledig
04-07-2025
Acte du Moniteur Capital & actions
Geoffrey GAUTHY
04-07-2025
Acte du Moniteur Modification des statuts
Geoffrey GAUTHY
22-05-2025
Acte du Moniteur Capital & actions
Geoffrey GAUTHY
22-05-2025
Acte du Moniteur Modification des statuts
Geoffrey GAUTHY
22-05-2025
Acte du Moniteur Changement de siège
Geoffrey GAUTHY
16-04-2025
Acte du Moniteur Changement d'administrateurs
20-03-2025
Acte du Moniteur Capital & actions
Geoffrey GAUTHY
2024
23-12-2024
Acte du Moniteur Modification des statuts
Geoffrey GAUTHY
23-12-2024
Acte du Moniteur Capital & actions
Geoffrey GAUTHY
25-07-2024
Dépôt BNB Comptes annuels déposés
exercice 2023 · volledig
2023
14-11-2023
Acte du Moniteur Capital & actions
Geoffrey GAUTHY
10-07-2023
Dépôt BNB Comptes annuels déposés
exercice 2022 · volledig
17-02-2023
Acte du Moniteur Changement d'administrateurs
Jean-Michel GAUTHY
17-02-2023
Acte du Moniteur Capital & actions
Jean-Michel GAUTHY
2022
02-08-2022
Dépôt BNB Comptes annuels déposés
exercice 2021 · volledig
2021
26-08-2021
Dépôt BNB Comptes annuels déposés
exercice 2020 · volledig
2020
16-07-2020
Dépôt BNB Comptes annuels déposés
exercice 2019 · volledig
2019
24-06-2019
Dépôt BNB Comptes annuels déposés
exercice 2018 · volledig
2018
16-07-2018
Dépôt BNB Comptes annuels déposés
exercice 2017 · volledig
2017
12-07-2017
Dépôt BNB Comptes annuels déposés
exercice 2016 · volledig
2016
18-07-2016
Dépôt BNB Comptes annuels déposés
exercice 2015 · volledig
Moniteur belge — actes 13 actes
Évolution du capital · 6
04-07-2025
Modification du capital
22-05-2025
Modification du capital
20-03-2025
Modification du capital
23-12-2024
Modification du capital
14-11-2023
Modification du capital
17-02-2023
Modification du capital
Évolution de l'adresse · 1
22-05-2025
Changement de siège
Tous les actes · 13 mis à jour il y a 9 mois
2025
16-09-2025 1 administrateur nommé, 1 démissionnaire Changement d'administrateurs
  • Charles Nelles — Bestuurder
  • Michael Mellink — Bestuurder
Détails techniques 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Michael Mellink",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-08-01",
      "evidence_quote": "la pr\u00E9sente assembl\u00E9e a \u00E9t\u00E9 convoqu\u00E9e avec l\u0027ordre du jour suivant : - D\u00E9mission de Monsieur Michael Mellink en tant qu\u0027administrateur avec effet imm\u00E9diat;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Charles Nelles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-08-01",
      "evidence_quote": "Nomination de Monsieur Charles Nelles en tant qu\u0027administrateur avec effet imm\u00E9diat et pour une dur\u00E9e de 6 ans:",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Michael Mellink",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "La d\u00E9mission avec effet imm\u00E9diat de Monsieur Michael Mellink a \u00E9t\u00E9 accept\u00E9e;",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Charles Nelles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "La nomination, avec effet imm\u00E9diat, de Monsieur Charles Nelles pour une dur\u00E9e de 6 ans a \u00E9t\u00E9 accept\u00E9e.",
      "decharge_status": "granted",
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Liege",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-09-16",
    "filing_date": "2025-08-01",
    "act_kind_objet": "Objet de l\u0027acte"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-07-02",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "SA",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0473.951.403",
    "org_name": "JACQUES \u0026 ASSOCIES SRL",
    "person_name": null,
    "org_rep_person_name": "Julien JACQUES",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Proc\u00E8s-verbal de l\u0027AGO du 02/07/2025"
  ],
  "corrected_publication_numac": null
}
04-07-2025 Augmentation de capital de 1.823.821,43 € à 5.936.277,23 € Capital & actions·Geoffrey GAUTHY
  • €4.112.455,80 → €5.936.277,23
  • 2 kapitaalbewegingen in deze akte
Notaire: Geoffrey GAUTHY · Herstal
Détails techniques 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 5936277.23,
      "delta_eur": 1823821.43,
      "before_eur": 4112455.8,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 39516,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 46.154
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 1823821.43,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 5486277.23,
      "delta_eur": -450000.0,
      "before_eur": 5936277.23,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": "kapitalisering_reserves",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-07-04",
    "filing_date": "2025-07-02",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-07-02",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 43420,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 70616,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 42414,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 97211,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 9013,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
04-07-2025 Modification des statuts — traduction des statuts, coordination des statuts et modification d'articles spécifiques Modification des statuts·Geoffrey GAUTHY
Notaire: Geoffrey GAUTHY · Herstal
Détails techniques 
{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-07-04",
    "filing_date": "2025-07-02",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-07-02",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "capital_change_consequence",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full_after": "AQUILON PHARMACEUTICALS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "AQUILON PHARMACEUTICALS",
    "current_zetel_raw": "Rue du Bois St-Jean 15/1, 4102 Seraing",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Le capital est fix\u00E9 \u00E0 5.486.277,23 \u20AC et repr\u00E9sent\u00E9 par 262.674 actions sans d\u00E9signation de valeur nominale, dont 43.420 de classe A, 70.616 de classe B, 42.414 de classe C, 97.211 de classe D, et 9.013 de classe E.",
      "new_text": "Le capital est fix\u00E9 \u00E0 cinq millions quatre cent quatre-vingt-six mille deux cent septante-sept euros vingt-trois cents (5.486.277,23 \u20AC). Il est repr\u00E9sent\u00E9 par 262.674 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/262.674e de l\u2019avoir social, dont 43.420 actions de classe A, 70.616 actions de classe B, 42.414 actions de classe C, 97.211 actions de classe D, ",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5 \u00A71er"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 262674,
    "shares_before": 262674,
    "capital_after_eur": 5486277.23,
    "capital_before_eur": 4112455.8,
    "share_classes_after": [
      {
        "count": 7521,
        "label": "A",
        "rights_summary": "Droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 7796,
        "label": "C",
        "rights_summary": "Droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 24199,
        "label": "D",
        "rights_summary": "Droit de vote",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}
22-05-2025 Augmentation de capital de 466.056,96 € à 4.112.455,80 € Capital & actions·Geoffrey GAUTHY
  • €3.646.398,84 → €4.112.455,80
  • Inbreng in natura · Apport en nature
  • 2 kapitaalbewegingen in deze akte
Notaire: Geoffrey GAUTHY · Herstal
Détails techniques 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 3646398.84,
      "delta_eur": 430304.0,
      "before_eur": 3216094.84,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 15368,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 28.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 430304.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 4112455.8,
      "delta_eur": 466056.96,
      "before_eur": 3646398.84,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 16658,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 466056.96,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-05-22",
    "filing_date": "2025-05-20",
    "act_kind_objet": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-05-20",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 35899,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 70616,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 34618,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 73012,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 9013,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
22-05-2025 Modification des statuts — traduction des statuts, coordination des statuts et modification d'articles spécifiques Modification des statuts·Geoffrey GAUTHY
Notaire: Geoffrey GAUTHY · Herstal
Détails techniques 
{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-05-22",
    "filing_date": "2025-05-20",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-05-20",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "capital_change_consequence",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full_after": "AQUILON PHARMACEUTICALS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "AQUILON PHARMACEUTICALS",
    "current_zetel_raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "The article defining the capital and share structure was replaced with new text reflecting the post-increase capital of \u20AC4,112,455.80 and the new share class distribution.",
      "new_text": "Le capital est fix\u00E9 \u00E0 quatre millions cent douze mille quatre cent cinquante-cinq euros quatre-vingt cents (4.112.455,80 \u20AC). Il est repr\u00E9sent\u00E9 par 223.158 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/222.593e de l\u2019avoir social, dont 35.899 actions de classe A, 70.616 actions de classe B, 34.618 actions de classe C, 73.012 actions de classe D, et 9.013 act",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5 \u00A7 1er"
    },
    {
      "summary": "The article defining the annual general meeting date was replaced with new text.",
      "new_text": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire se r\u00E9unit annuellement le dernier jeudi de juin \u00E0 seize heures.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "24 alin\u00E9a 1er"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": "*25333276*",
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": false
  },
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 223158,
    "shares_before": 206500,
    "capital_after_eur": 4112455.8,
    "capital_before_eur": 3646398.84,
    "share_classes_after": [
      {
        "count": 35899,
        "label": "A",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 70616,
        "label": "B",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 34618,
        "label": "C",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 73012,
        "label": "D",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 9013,
        "label": "E",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}
22-05-2025 Transfert du siège social de Visé à Seraing Changement de siège·Geoffrey GAUTHY
  • Rue Porte de Lorette(VIS) 76 : 4600 Visé → 4102 Seraing, rue du Bois Saint-Jean, 15/1
Notaire: Geoffrey GAUTHY · Herstal
Détails techniques 
{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_administratif",
      "new_address": {
        "raw": "4102 Seraing, rue du Bois Saint-Jean, 15/1",
        "city": "Seraing",
        "region": "waals_gewest",
        "street": "du Bois Saint-Jean",
        "country": "BE",
        "postcode": "4102",
        "box_number": null,
        "street_number": "15/1",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
        "city": "Vis\u00E9",
        "region": "waals_gewest",
        "street": "Porte de Lorette",
        "country": "BE",
        "postcode": "4600",
        "box_number": null,
        "street_number": "76",
        "locality_suffix": "(VIS)"
      },
      "effective_date": null,
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "not_specified",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-05-22",
    "filing_date": "2025-05-20",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2025-05-20",
    "unanimous": null
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ]
}
16-04-2025 2 reconduits Changement d'administrateurs
  • Paul Maes — Commissaris
  • Gauthier Van Der Elst — Commissaris
Détails techniques 
{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Paul Maes",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Maes PharmConsult Srl",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-04",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Gauthier Van Der Elst",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Scale I",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-04",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Vis\u00E9",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-04-16",
    "filing_date": "2024-06-04",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-07-16",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "SRL Jacques \u0026 Associ\u00E9s",
    "person_name": "Julien JACQUES",
    "org_rep_person_name": "Julien JACQUES",
    "person_role_at_subject": "mandataire"
  },
  "co_filed_documents": [
    "copie du Proc\u00E8s-verbal de I\u0027AGO du 16/07/2024",
    "procuration"
  ],
  "corrected_publication_numac": null
}
20-03-2025 Augmentation de capital de 449.990,19 € à 3.465.910,84 € Capital & actions·Geoffrey GAUTHY
  • €3.015.920,65 → €3.465.910,84
  • Inbreng in natura · Apport en nature
  • 3 kapitaalbewegingen in deze akte
Notaire: Geoffrey GAUTHY · Herstal
Détails techniques 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2766104.65,
      "delta_eur": 249816.0,
      "before_eur": 2516288.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 8922,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 28.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 249816.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 3015920.65,
      "delta_eur": 249816.0,
      "before_eur": 2766104.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 8922,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 28.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 249816.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 3465910.84,
      "delta_eur": 449990.19,
      "before_eur": 3015920.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 16251,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 27.69
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 449990.19,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-03-20",
    "filing_date": "2025-03-18",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-03-14",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 31446,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 59716,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 30149,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 61166,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 8655,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
2024
23-12-2024 Modification des statuts — traduction des statuts, coordination des statuts et modification d'articles spécifiques Modification des statuts·Geoffrey GAUTHY
Notaire: Geoffrey GAUTHY · HerstalÉtude: GAUTHY, JACQUES & ROLANS – Société Notariale
Détails techniques 
{
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-12-23",
    "filing_date": "2024-12-19",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-12-19",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "other",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "individual_name": "DEMONCEAU David"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full_after": "AQUILON PHARMACEUTICALS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "AQUILON PHARMACEUTICALS",
    "current_zetel_raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Le capital est fix\u00E9 \u00E0 2.516.288,65 \u20AC et repr\u00E9sent\u00E9 par 165.959 actions sans d\u00E9signation de valeur nominale, dont 5 classes (A \u00E0 E) jouissant des m\u00EAmes droits.",
      "new_text": "Le capital est fix\u00E9 \u00E0 deux millions cinq cent seize mille deux cent quatre-vingt-huit euros soixante-cinq cents (2.516.288,65 \u20AC). Il est repr\u00E9sent\u00E9 par 165.959 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/165.959e) de l\u2019avoir social, dont 27.876 actions de classe A, 43.465 actions de classe B, 29.792 actions de classe C, 56.171 actions de classe D, et 8.6",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5 \u00A71er"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey GAUTHY",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 165959,
    "shares_before": 165959,
    "capital_after_eur": 2516288.65,
    "capital_before_eur": 2619395.19,
    "share_classes_after": [
      {
        "count": 27876,
        "label": "A",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 43465,
        "label": "B",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 29792,
        "label": "C",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 56171,
        "label": "D",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      },
      {
        "count": 8655,
        "label": "E",
        "rights_summary": "droit de vote",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}
23-12-2024 Réduction de capital de 450.000 € à 2.516.288,65 € Capital & actions·Geoffrey GAUTHY
  • €2.966.288,65 → €2.516.288,65
  • 2 kapitaalbewegingen in deze akte
Notaire: Geoffrey GAUTHY · HerstalÉtude: GAUTHY, JACQUES & ROLANS – Société Notariale
Détails techniques 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2966288.65,
      "delta_eur": 346893.46,
      "before_eur": 2619395.19,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 7516,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 46.154
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 346893.46,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 2516288.65,
      "delta_eur": -450000.0,
      "before_eur": 2966288.65,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-12-23",
    "filing_date": "2024-12-19",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-12-19",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "DEMONCEAU David"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 27876,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 43465,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 29792,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 56171,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 8655,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
2023
14-11-2023 Réduction de capital de 762.000 € à 2.619.395,19 € Capital & actions·Geoffrey GAUTHY
  • €3.381.395,19 → €2.619.395,19
  • 2 kapitaalbewegingen in deze akte
Notaire: Geoffrey GAUTHY · HerstalÉtude: GAUTHY, JACQUES & ROLANS – Société Notariale
Détails techniques 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 3381395.19,
      "delta_eur": 348278.08,
      "before_eur": 3033117.11,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 7546,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 46.154
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 348278.08,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 2619395.19,
      "delta_eur": -762000.0,
      "before_eur": 3381395.19,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": "kapitalisering_reserves",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-11-14",
    "filing_date": "2023-11-10",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-11-09",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "DEMONCEAU David"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 26924,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 43465,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 28335,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 51064,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 8655,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
17-02-2023 5 administrateurs nommés, 3 démissionnaires Changement d'administrateurs·Jean-Michel GAUTHY
  • BENAMEUR Hassan — Bestuurder
  • MELLINK Michäel — Bestuurder
  • MANOR Moshe — Bestuurder
  • VAN DER ELST Gauthier — Bestuurder
  • David DEMONCEAU — Bestuurder
  • JEANMART Patrick — Bestuurder
  • DE GHELDERE Joseph — Bestuurder
  • STREEL Micheline — Bestuurder
Notaire: Jean-Michel GAUTHY · HerstalÉtude: GAUTHY, JACQUES & ROLANS – Société Notariale
Détails techniques 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "JEANMART Patrick",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 Monsieur JEANMART Patrick",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "DE GHELDERE Joseph",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 Monsieur DE GHELDERE Joseph",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "STREEL Micheline",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "SAMBRINVEST SPIN-OFF/SPIN-OUT",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 La soci\u00E9t\u00E9 \u00AB SAMBRINVEST SPIN-OFF/SPIN-OUT \u00BB dont le repr\u00E9sentant permanent est Madame STREEL Micheline",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "BENAMEUR Hassan",
        "address": "69003 Lyon (France), rue Pierre Bonnaud, 61",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur BENAMEUR Hassan, domicili\u00E9 \u00E0 69003 Lyon (France), rue Pierre Bonnaud, 61, comme administrateur ind\u00E9pendant",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "MELLINK Mich\u00E4el",
        "address": "Hilversumseweg 14a 1251EX Laren (Pays-Bas)",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur MELLINK Mich\u00E4el, domicili\u00E9 \u00E0 Hilversumseweg 14a 1251EX Laren (Pays-Bas), comme administrateur de classe B",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "MANOR Moshe",
        "address": "Hacarmek st, Ramat Hasharon, 4723007 Israel",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur MANOR Moshe, domicili\u00E9 \u00E0 Hacarmek st, Ramat Hasharon, 4723007 Israel, comme administrateur de classe D",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "VAN DER ELST Gauthier",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Suite \u00E0 la r\u00E9solution qui pr\u00E9c\u00E8de, l\u2019assembl\u00E9e g\u00E9n\u00E9rale constate que Monsieur VAN DER ELST Gauthier est un administrateur des classes C et E.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "David DEMONCEAU",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u2019entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "SAINTENOY, COMHAIRE \u0026 CO",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "du rapport \u00E9tabli par la soci\u00E9t\u00E9 \u00AB SAINTENOY, COMHAIRE \u0026 CO \u00BB, repr\u00E9sent\u00E9e par Monsieur David DEMONCEAU, r\u00E9viseur d\u2019entreprises, en date du 27 janvier 2023",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "correction",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": "rectification",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-02-17",
    "filing_date": "2023-02-15",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2023-02-13",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2018-11-30",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Jean-Michel GAUTHY",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire"
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du r\u00E9viseur",
    "la coordination des statuts"
  ],
  "corrected_publication_numac": null
}
17-02-2023 Augmentation de capital de 1.509.881,96 € à 4.543.000,07 € Capital & actions·Jean-Michel GAUTHY
  • €3.033.117,11 → €4.543.000,07
  • 3 kapitaalbewegingen in deze akte
Notaire: Jean-Michel GAUTHY · HerstalÉtude: GAUTHY, JACQUES & ROLANS – Société Notariale
Détails techniques 
{
  "events": [
    {
      "kind": "eenhoofdigheid_declaration",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "JEANMART Patrick",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "SAMBRINVEST SPIN-OFF/SPIN-OUT",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "DE GHELDERE Joseph",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "BENAMEUR Hassan",
          "share_class": "B",
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "MELLINK Mich\u00E4el",
          "share_class": "B",
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "MANOR Moshe",
          "share_class": "D",
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "VAN DER ELST Gauthier",
          "share_class": "C",
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "VAN DER ELST Gauthier",
          "share_class": "E",
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 1523235.16,
      "delta_eur": -1201147.77,
      "before_eur": 2724382.93,
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 3033117.11,
      "delta_eur": 1509881.95,
      "before_eur": 1523235.16,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 32714,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 46.154
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 4543000.07,
      "delta_eur": 1509881.96,
      "before_eur": 3033117.11,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 32714,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 46.154
      },
      "decrease_purpose": null,
      "contribution_type": "kapitalisering_reserves",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-02-17",
    "filing_date": "2023-02-15",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-02-13",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "SAINTENOY, COMHAIRE \u0026 CO",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "David DEMONCEAU"
  },
  "subject_company": {
    "kbo": "0540.870.218",
    "name_full": "AQUILON PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du r\u00E9viseur",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 26924,
      "class_name": "A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 43465,
      "class_name": "B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 27130,
      "class_name": "C",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 44723,
      "class_name": "D",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 8655,
      "class_name": "E",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}
Avis de crédit avis par client et montant

Ce client peut-il acheter un montant X à crédit ? Indiquez le montant et le délai — vous recevez immédiatement un avis VERT/ORANGE/ROUGE, avec maximum suggéré et conditions concrètes.

Fondé sur des sources officielles (BNB, BCE, Moniteur). Indicatif, pas un conseil de crédit.
Rapport de due diligence IA Checked AI

Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.

Bientôt disponible
Généré par IA sur la base des données Checked ; indicatif, ni conseil juridique ni conseil en investissement.
Données d'entreprise (BCE) Banque-Carrefour
Activités
Recherche-développement en biotechnologie72101Recherche-développement en biotechnologie72110Autres activités pour la santé humaine n.c.a.86909Activités dans le domaine de l’alimentation86995
Activité principale en évidence.
Noms & noms commerciaux
Dénomination légaleFR AQUILON PHARMACEUTICALS
Siège social
Rue du Bois St-Jean 15/1
4102 Seraing, Belgique
Données officielles de la Banque-Carrefour des Entreprises (BCE). Disponibles pour toutes les entreprises enregistrées.
Entreprises similaires Même NACE
Biocubik BE 0782.955.294 · Seraing
Greenewable Consulting & Management BE 0797.048.505 · Seraing
DIAGENODE BE 0480.422.786 · Seraing
EYED PHARMA BE 0508.599.605 · Seraing
KANEKA EUROGENTEC BE 0427.348.346 · Seraing
Source : Moniteur belge, BCE, BNB · généré via checked.be · indicatif